FDA approval of post-surgery #pembro + belzutifan adds a treatment option for patients with higher-risk #ccRCC. But does it change practice? Read more from Dr. Stepan M. Esagian, Dr. Pavlos Msaouel, and Dr. Andrew W. Hahn for #ASCODailyNews: https://bit.ly/4ABHaF2